{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T06:15:18Z","timestamp":1761718518431},"publisher-location":"Cham","reference-count":22,"publisher":"Springer International Publishing","isbn-type":[{"type":"print","value":"9783319596587"},{"type":"electronic","value":"9783319596594"}],"license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016]]},"DOI":"10.1007\/164_2016_55","type":"book-chapter","created":{"date-parts":[[2016,10,17]],"date-time":"2016-10-17T04:19:38Z","timestamp":1476677978000},"page":"167-175","source":"Crossref","is-referenced-by-count":2,"title":["Ivabradine"],"prefix":"10.1007","author":[{"given":"Michel","family":"Komajda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,10,18]]},"reference":[{"issue":"8","key":"55_CR1","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1093\/eurjhf\/hft032","volume":"15","author":"P Abrahamsson","year":"2013","unstructured":"Abrahamsson P, Swedberg K, Borer JS, B\u00f6hm M, Kober L, Komajda M, Lloyd SM, Metra M, Tavazzi L, Ford I (2013) Risk following hospitalization in stable chronic systolic heart failure. Eur J Heart Fail 15(8):885\u2013891","journal-title":"Eur J Heart Fail"},{"issue":"5","key":"55_CR2","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1002\/ejhf.258","volume":"17","author":"M B\u00f6hm","year":"2015","unstructured":"B\u00f6hm M, Borer JS, Camm J, Ford I, Lloyd SM, Komajda M, Tavazzi L, Talajic M, Lainscak M, Reil JC, Ukena C, Swedberg K (2015) Twenty-four-hour heart rate lowering with ivabradine in chronic heart failure: insights from the SHIFT Holter substudy. Eur J Heart Fail 17(5):518\u2013526","journal-title":"Eur J Heart Fail"},{"issue":"22","key":"55_CR3","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.1093\/eurheartj\/ehs259","volume":"33","author":"JS Borer","year":"2012","unstructured":"Borer JS, B\u00f6hm M, Ford I, Komajda M, Tavazzi L, Sendon JL, Alings M, Lopez-de-Sa E, Swedberg K, on behalf of the SHIFT Investigators (2012) Effect of ivabradine on recurrent hospitalization for worsening heart failure in patients with chronic systolic heart failure: the SHIFT Study. Eur Heart J 33(22):2813\u20132820","journal-title":"Eur Heart J"},{"issue":"6","key":"55_CR4","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.ejheart.2008.04.005","volume":"10","author":"GM De Ferrari","year":"2008","unstructured":"De Ferrari GM, Mazzuero A, Agnesina L, Bertoletti A, Lettino M, Campana C, Schwartz PJ, Tavazzi L (2008) Favourable effects of heart rate reduction with intravenous administration of ivabradine in patients with advanced heart failure. Eur J Heart Fail 10(6):550\u2013555","journal-title":"Eur J Heart Fail"},{"key":"55_CR5","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.phrs.2006.03.006","volume":"53","author":"D Di Francesco","year":"2006","unstructured":"Di Francesco D (2006) Funny channels in the control of cardiac rhythm and mode of action of selective blockers. Pharmacol Res 53:399\u2013406","journal-title":"Pharmacol Res"},{"key":"55_CR6","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1093\/eurheartj\/ehr343","volume":"32","author":"I Erkman","year":"2011","unstructured":"Erkman I, Chassany O, Komajda M, B\u00f6hm M, Borer JS, Ford I, Tavazzi L, Swedberg K (2011) Heart rate reduction with ivabradine and health related quality of life in patients with chronic heart failure: results from the SHIFT study. Eur Heart J 32:2395\u20132404","journal-title":"Eur Heart J"},{"key":"55_CR7","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/S0735-1097(00)00531-3","volume":"35","author":"CP Green","year":"2000","unstructured":"Green CP, Porter CB, Bresnahan DR, Spertus JA (2000) Development and evaluation of the Kansas City Cardiomyopathy Questionnaire: a new health status measure for heart failure. J Am Coll Cardiol 35:1245\u20131255","journal-title":"J Am Coll Cardiol"},{"key":"55_CR8","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1093\/oxfordjournals.eurheartj.a060471","volume":"15","author":"G Hasenfuss","year":"1994","unstructured":"Hasenfuss G, Holubarsch C, Hermann HP, Astheimer K, Pieske B, Just H (1994) Influence of the force-frequency relationship on haemodynamics and left ventricular function in patients with non-failing hearts and in patients with dilated cardiomyopathy. Eur Heart J 15:164\u2013170","journal-title":"Eur Heart J"},{"key":"55_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2016.04.136","author":"FJ Hidalgo","year":"2016","unstructured":"Hidalgo FJ, Auguita M, Castillo JC, Rodriguez S, Pardo L, Duran E, Sanchez J, Ferreiro C, Pan M, Mesa D, Delgado M, Ruiz M (2016) Effect of early treatment with ivabradine combined with beta-blockers versus beta-blockers alone in patients hospitalised with heart failure and reduced left ventricular ejection fraction (ETHIC-AHF): a randomised study. Int J Cardiol. doi: 10.1016\/j.ijcard.2016.04.136","journal-title":"Int J Cardiol"},{"issue":"7","key":"55_CR10","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1002\/ejhf.114","volume":"16","author":"M Komajda","year":"2014","unstructured":"Komajda M, B\u00f6hm M, Borer JS, Ford I, Robertson M, Manolis AJ, Tavazzi L, Swedberg K, on behalf of the SHIFT Investigators (2014) Efficacy and safety of ivabradine in patients with chronic systolic heart failure according to blood pressure level in SHIFT. Eur J Heart Fail 16(7):810\u2013816","journal-title":"Eur J Heart Fail"},{"issue":"12","key":"55_CR11","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1002\/ejhf.347","volume":"17","author":"M Komajda","year":"2015","unstructured":"Komajda M, Tavazzi L, Francq BG, B\u00f6hm M, Borer JS, Ford I, Swedberg K, on behalf of the SHIFT trial (2015) Efficacy and safety of ivabradine in patients with chronic systolic heart failure and diabetes: an analysis from the SHIFT trial. Eur J Heart Fail 17(12):1294\u20131301","journal-title":"Eur J Heart Fail"},{"key":"55_CR12","doi-asserted-by":"crossref","unstructured":"Komajda M, Tavazzi L, Swedberg K, B\u00f6hm M, Borer JS, Moyne A, Ford I, on behalf of the SHIFT Investigators (2016) Chronic exposure to ivabradine reduces readmissions in the vulnerable phase after hospitalization for worsening systolic heart failure: a post-hoc analysis of SHIFT. Eur J Heart Fail. doi:10\u20131002\/ejhf.582","DOI":"10.1002\/ejhf.582"},{"issue":"13","key":"55_CR13","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1161\/01.CIR.0000118464.48959.1C","volume":"109","author":"P Mulder","year":"2004","unstructured":"Mulder P, Barbier S, Chagraoui A, Richard V, Henry JP, Lallemand F, Renet S, Lerebours G, Mahlberg-Gaudin F, Thuillez G (2004) Long-term heart rate reduction induced by the selective I(f) current inhibitor ivabradine improves left ventricular function and intrinsic myocardial structure in congestive heart failure. Circulation 109(13):1674\u20131679","journal-title":"Circulation"},{"issue":"5","key":"55_CR14","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1161\/01.CIR.85.5.1743","volume":"85","author":"LA Mulieri","year":"1992","unstructured":"Mulieri LA, Hasenfuss G, Leavitt B, Allen PD, Alpert NR (1992) Altered myocardial force-frequency relation in human heart failure. Circulation 85(5):1743\u20131750","journal-title":"Circulation"},{"key":"55_CR15","doi-asserted-by":"crossref","unstructured":"Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JG, Coats AJ, Falk V, Gonz\u00e1lez-Juanatey JR, Harjola VP, Jankowska EA, Jessup M, Linde C, Nihoyannopoulos P, Parissis JT, Pieske B, Riley JP, Rosano GM, Ruilope LM, Ruschitzka F, Rutten FH, van der Meer P, Authors\/Task Force Members; Document Reviewers (2016) 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. pii:ehw128. [Epub ahead of print]","DOI":"10.1093\/eurheartj\/ehw128"},{"key":"55_CR16","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1016\/j.jacc.2013.07.027","volume":"62","author":"JC Reil","year":"2013","unstructured":"Reil JC, Tardif JC, Ford I, Lloyd SM, O\u2019Meara E, Komajda M, Borer JS, Tavazzi L, Swedberg K, B\u00f6hm M (2013) Selective heart rate reduction with ivabradine unloads the left ventricle in heart failure patients. J Am Coll Cardiol 62:1977\u20131985","journal-title":"J Am Coll Cardiol"},{"key":"55_CR17","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S1388-9842(01)00198-2","volume":"4","author":"S Stewart","year":"2002","unstructured":"Stewart S, Jenkins A, Buchan S, McGuire A, Capewell S, McMurray JJ (2002) The current cost of heart failure to the National Health Service in the UK. Eur J Heart Fail 4:361\u2013371","journal-title":"Eur J Heart Fail"},{"key":"55_CR18","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/S0140-6736(10)61198-1","volume":"376","author":"K Swedberg","year":"2010","unstructured":"Swedberg K, Komajda M, B\u00f6hm M, Borer JS, Ford I, Dubost-Brama A, Lerebours G, Tavazzi L, on behalf of the SHIFT Investigators (2010) Ivabradine and outcomes in chronic heart failure (SHIFT): a randomized placebo controlled study. Lancet 376:875\u2013885","journal-title":"Lancet"},{"key":"55_CR19","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1093\/eurheartj\/ehr311","volume":"32","author":"JC Tardif","year":"2011","unstructured":"Tardif JC, O\u2019Meara E, Komajda M, B\u00f6hm M, Borer JS, Ford I, Tavazzi L, Swedberg K, on behalf of the SHIFT Investigators (2011) Effects of selective heart rate reduction with ivabradine on left ventricular remodeling and function: results from the SHIFT echocardiography substudy. Eur Heart J 32:2507\u20132515","journal-title":"Eur Heart J"},{"issue":"2","key":"55_CR20","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.ijcard.2013.10.068","volume":"170","author":"L Tavazzi","year":"2013","unstructured":"Tavazzi L, Swedberg K, Komajda M, B\u00f6hm M, Borer JS, Lainscak M, Robertson M, Ford I, on behalf of the SHIFT Investigators (2013) Clinical profiles and outcomes in patients with chronic heart failure and chronic obstructive pulmonary disease: an efficacy and safety analysis of SHIFT study. Int J Cardiol 170(2):182\u2013188","journal-title":"Int J Cardiol"},{"key":"55_CR21","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.phrs.2006.03.016","volume":"53","author":"JP Vilaine","year":"2006","unstructured":"Vilaine JP (2006) The discovery of the selective I(f) current inhibitor ivabradine. A new therapeutic approach to ischemic heart disease. Pharmacol Res 53:424\u2013434","journal-title":"Pharmacol Res"},{"key":"55_CR22","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1002\/ejhf.59","volume":"16","author":"AA Voors","year":"2014","unstructured":"Voors AA, van Veldhuisen DJ, Robertson M, Ford I, Borer JS, B\u00f6hm M, Komajda M, Swedberg K, Tavazzi L, on behalf of the SHIFT Investigators (2014) The effect of heart rate reduction with ivabradine on renal function in patients with chronic heart failure: an analysis from SHIFT. Eur J Heart Fail 16:426\u2013434","journal-title":"Eur J Heart Fail"}],"container-title":["Handbook of Experimental Pharmacology","Heart Failure"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/164_2016_55","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,14]],"date-time":"2019-09-14T13:37:07Z","timestamp":1568468227000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/164_2016_55"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"ISBN":["9783319596587","9783319596594"],"references-count":22,"URL":"https:\/\/doi.org\/10.1007\/164_2016_55","relation":{},"ISSN":["0171-2004","1865-0325"],"issn-type":[{"type":"print","value":"0171-2004"},{"type":"electronic","value":"1865-0325"}],"subject":[],"published":{"date-parts":[[2016]]}}}